Mednax Inc (MD)

Profitability ratios

Return on sales

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit margin 21.62% 20.32% 19.87% 20.42% 21.13% 21.68% 22.28% 22.95% 23.68% 25.00% 26.13% 26.62% 26.85% 26.40% 26.33% 26.18% 24.30% 24.26% 24.24% 24.40%
Operating profit margin 7.27% -0.23% 0.10% 0.08% 0.37% 8.69% 9.12% 9.27% 9.77% 10.46% 11.02% 11.09% 10.62% 9.14% 7.17% 6.21% 4.51% 4.90% -39.60% -34.24%
Pretax margin -5.03% -13.63% -13.38% -3.06% -2.42% 5.88% 6.33% 6.58% 4.13% 5.47% 5.70% 5.47% 7.08% 5.03% 2.93% 1.40% 0.52% 1.54% -42.81% -37.24%
Net profit margin -4.92% -12.65% -11.64% -2.59% -2.08% 5.59% 5.16% 5.14% 3.38% 4.32% 4.31% 4.75% 6.85% 1.05% -2.93% -41.46% -35.68% -26.56% -61.53% -36.30%

The profitability ratios of Mednax Inc show a mixed performance over the analyzed periods.

1. Gross Profit Margin:
The gross profit margin, which measures the percentage of revenue remaining after deducting the cost of goods sold, experienced fluctuations, starting around 24% in 2020, reaching a peak of 26.85% in December 2021, and then declining to 21.62% by December 2024.

2. Operating Profit Margin:
The operating profit margin reflects the company's ability to generate profit from its core operations. Mednax's operating profit margin has shown improvement, starting from negative values in 2020, increasing steadily to 11.09% by March 2022, before decreasing slightly to 7.27% by December 2024.

3. Pretax Margin:
The pretax margin, indicating the percentage of profit before taxes relative to total revenue, exhibited a similar trend as the operating profit margin. It started in negative territory in 2020, improved over the following years, reaching a peak of 7.08% in December 2021, and then declined to -5.03% by December 2024.

4. Net Profit Margin:
The net profit margin, which shows the percentage of profit generated from total revenue after all expenses have been deducted, displayed fluctuations. It started very low in 2020, saw improvements in 2021 and 2022, with a range between -2.59% to 6.85%, and then decreased to -4.92% by December 2024.

Overall, while the company showed improvements in its operating and pretax margins over the reviewed periods, the net profit margin experienced volatility and ended on a negative note by December 2024. It indicates challenges in efficiently converting revenue into bottom-line profits during the latter stages of the analysis period.


Return on investment

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating return on assets (Operating ROA) 6.79% -0.22% 0.10% 0.08% 0.33% 7.52% 7.89% 7.91% 8.21% 8.78% 9.12% 9.22% 7.45% 6.32% 5.04% 4.58% 3.01% 3.89% -36.81% -27.81%
Return on assets (ROA) -4.60% -12.22% -11.68% -2.38% -1.87% 4.83% 4.46% 4.38% 2.84% 3.62% 3.57% 3.95% 4.81% 0.72% -2.06% -30.60% -23.79% -21.11% -57.21% -29.48%
Return on total capital -7.14% -30.92% -31.36% -1.83% -1.17% 18.02% 19.37% 20.83% 16.03% 18.45% 20.47% 19.41% 24.28% 22.70% 24.59% 24.51% 22.83% 24.10% 22.42% 13.46%
Return on equity (ROE) -12.95% -34.65% -32.98% -6.04% -4.89% 11.61% 10.92% 11.18% 7.47% 9.83% 10.00% 10.53% 14.61% 2.27% -6.51% -99.14% -106.52% -89.82% -234.43% -85.62%

Based on the provided data, let's analyze the profitability ratios of Mednax Inc:

1. Operating return on assets (Operating ROA):
- Mednax's Operating ROA shows an improving trend over the quarters, steadily increasing from negative percentages to positive percentages. It indicates that the company's operating income generated from its assets has been increasing over the quarters.

2. Return on assets (ROA):
- The ROA of Mednax is fluctuating but generally improving from deep negative values to positive percentages over the quarters. This suggests that the company is becoming more efficient in generating profits from its total assets.

3. Return on total capital:
- Mednax's Return on Total Capital experienced a decline before recovering slightly but remained negative in the last few quarters. This ratio indicates a decrease in the company's ability to generate returns from both equity and debt capital used in its operations.

4. Return on equity (ROE):
- The ROE of Mednax depicts a mix of negative and positive values. While showing improvements over the quarters, the company's ability to generate profits from shareholders' equity remains volatile.

In summary, Mednax Inc has demonstrated improvements in its profitability ratios over the quarters, with Operating ROA and ROA showing positive trends. However, Return on Total Capital and ROE have been more volatile, indicating challenges in generating returns from both capital investments and shareholders' equity. Management should continue to focus on efficiency and profitability to sustain and enhance overall financial performance.